Dose-Response to Resistance Exercise on Cardiovascular Health

Recruiting N/A Interventional Study
Cardiovascular Risk
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
40 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
240 (estimated)
Sponsor
University of Pittsburgh · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
A large body of evidence indicates numerous health benefits of physical activity, including prevention of cardiovascular disease (CVD), the leading cause of death in the US. This evidence has led to US Physical Activity Guidelines that recommend ≥150 min/week of moderate or ≥75 min/week of vigorous aerobic exercise (AE), plus resistance exercise (RE; such as weight lifting) on ≥2 days/week. To dat…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Non-Smoker * Overweight or Obese: Body Mass Index 25-43 kg/m2 * Inactive: not meeting the US resistance and aerobic exercise guidelines over the last 6 months * Walking \<7,000 steps/day at baseline * Capable of performing the required exercise training Exclusion Criteria: A…
Contacts

Duck-chul Lee, PhD

412-383-4004

dclee@pitt.edu

CONTACT